These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 9308767)

  • 41. Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells.
    Pepke W; Eisenreich A; Jaster M; Ayral Y; Bobbert P; Mayer A; Schultheiss HP; Rauch U
    Cardiovasc Ther; 2013 Apr; 31(2):115-23. PubMed ID: 22212466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
    Thiec F; Cherel G; Christophe OD
    J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
    Wiiger MT; Prydz H
    Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation.
    Schecter AD; Giesen PL; Taby O; Rosenfield CL; Rossikhina M; Fyfe BS; Kohtz DS; Fallon JT; Nemerson Y; Taubman MB
    J Clin Invest; 1997 Nov; 100(9):2276-85. PubMed ID: 9410905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factor VIIa-tissue factor: functional importance of protein-membrane interactions.
    Morrissey JH; Neuenschwander PF; Huang Q; McCallum CD; Su B; Johnson AE
    Thromb Haemost; 1997 Jul; 78(1):112-6. PubMed ID: 9198138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor cells expressing tissue factor influence the migration of smooth muscle cells in a catalytic activity-dependent way.
    Brousseau C; Morissette G; Fortin JP; Marceau F; Petitclerc E
    Can J Physiol Pharmacol; 2009 Sep; 87(9):694-701. PubMed ID: 19794520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
    Almus FE; Rao LV; Rapaport SI
    Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIa.
    Valentin S; Reutlingsperger CP; Nordfang O; Lindhout T
    Thromb Haemost; 1995 Dec; 74(6):1478-85. PubMed ID: 8772224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model.
    Lefkovits J; Malycky JL; Rao JS; Hart CE; Plow EF; Topol EJ; Nicolini FA
    J Am Coll Cardiol; 1996 Dec; 28(7):1858-65. PubMed ID: 8962577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
    van 't Veer C; Mann KG
    J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent.
    Kelley RF; Refino CJ; O'Connell MP; Modi N; Sehl P; Lowe D; Pater C; Bunting S
    Blood; 1997 May; 89(9):3219-27. PubMed ID: 9129026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
    Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
    J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of beta2-glycoprotein I on tissue factor activity.
    Ieko M; Yasukouchi T; Sawada KI; Koike T
    Semin Thromb Hemost; 1998; 24(3):211-5. PubMed ID: 9701450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII.
    Yada K; Nogami K; Ogiwara K; Shibata M; Shima M
    Thromb Haemost; 2011 Jun; 105(6):989-98. PubMed ID: 21437361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
    Sevinsky JR; Rao LV; Ruf W
    J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
    van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
    Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.
    Bajaj SP; Joist JH
    Semin Thromb Hemost; 1999; 25(4):407-18. PubMed ID: 10548073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticoagulant actions of tissue factor pathway inhibitor on tissue-factor-dependent plasma coagulation.
    Ofosu FA
    Semin Thromb Hemost; 1995; 21(2):240-4. PubMed ID: 7660146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface.
    Ghosh S; Ezban M; Persson E; Pendurthi U; Hedner U; Rao LV
    J Thromb Haemost; 2007 Feb; 5(2):336-46. PubMed ID: 17092304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.